Parents launch petition for autism, Fragile X funding

05/23/2013 | PharmaLive.com

Parents of children with autism launched an online petition urging the government and industry to help fund Seaside's work on a drug for autism and Fragile X syndrome. Roche Holding declined to exercise an option that would have provided funding after Seaside's experimental drug arbaclofen failed to meet clinical endpoints in a Phase IIb trial.

View Full Article in:

PharmaLive.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX